Attributes | Values |
---|
rdf:type
| |
description
| - article scientifique publié en 2006 (fr)
- artículu científicu espublizáu en 2006 (ast)
- wetenschappelijk artikel (gepubliceerd op 2006/01/01) (nl)
- vedecký článok (publikovaný 2006/01/01) (sk)
- vědecký článek publikovaný v roce 2006 (cs)
- مقالة علمية (نشرت عام 2006) (ar)
- 2006 թվականի հունվարին հրատարակված գիտական հոդված (hy)
- наукова стаття, опублікована в січні 2006 (uk)
- 2006 թուականի Յունուարին հրատարակուած գիտական յօդուած (hyw)
- scientific journal article (en)
- im Januar 2006 veröffentlichter wissenschaftlicher Artikel (de)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - Xiao-Ying Hua
- George Kokotos
- Daren Stephens
- Bethany Fitzsimmons
- Tony L. Yaksh
- Camilla I. Svensson
- Christoforos G. Kokotos
|
rdfs:label
| - Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (en)
- Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (nl)
- Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (ast)
|
skos:prefLabel
| - Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (en)
- Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (nl)
- Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (ast)
|
name
| - Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (en)
- Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (nl)
- Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (ast)
|
author
| |
author
| |
title
| |
title
| - Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
ResearchGate publication ID
| |
ResearchGate publication ID
| |
is about
of | |
is cites work
of | - Phospholipase A2 superfamily members play divergent roles after spinal cord injury
- Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes
- Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes
- Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis.
- Phospholipase A2 structure/function, mechanism, and signaling
- Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine
- Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury.
- Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010--present).
- Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention
- A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity
- p38 MAPK, microglial signaling, and neuropathic pain
- Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases.
- 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides
- Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
- Respiratory allergies: a general overview of remedies, delivery systems, and the need to progress
- Liberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease
- Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2
- Location of inhibitors bound to group IVA phospholipase A2 determined by molecular dynamics and deuterium exchange mass spectrometry
- Inhibition of spinal cytosolic phospholipase A(2) expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesia.
- Analgesic properties of a peripherally acting and GalR2 receptor-preferring galanin analog in inflammatory, neuropathic, and acute pain models.
- Synthesis of 2-oxoamides based on sulfonamide analogs of gamma-amino acids and their activity on phospholipase A2.
- BmPLA2 containing conserved domain WD40 affects the metabolic functions of fat body tissue in silkworm, Bombyx mori
- 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2.
- Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat
- Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.
- 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity
- Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics
- 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A2 inhibitors
|
is cites work
of | |